Dr. Jiang Hualiang (蒋华良), aged 57, is an independent non-executive Director of our

Company. He was appointed as an independent non-executive Director of our Company in January 15, 2021 and is primarily responsible for supervising and providing independent judgment to our Board.

 

Dr. Jiang joined Shanghai Institute of Materia Medica, Chinese Academy of Sciences (中国科学院上海药物研究所) in August 1995 and successively served as different positions including a research fellow, a director and a research director of State Key Laboratory of Drug Research (新药研究国家重点实验室). He is also serving as an adjunct professor at Shenyang Pharmaceutical University (沈阳药科大学) since September 2015. He was nominated as an independent non-executive director of Shanghai Junshi Biosciences Co., Ltd. on September 30, 2020. Dr. Jiang was recognized as an Academician of Chinese Academy of Sciences (中国科学院院士) in November 2017. Dr. Jiang was awarded the Second Prize of State Technological Invention Award (国家技术发明奖二等奖) by State Council of the People’s Republic of China (中华人民共和国国务院) in 2017, the First Prize of Shanghai Science and Technology Award (上海市科学技术奖一等奖) by Shanghai Municipal People’s Government (上海市人民政府) twice in 2003 and 2015 and the Second Prize of National Natural Science Award (国家自然科学奖二等奖) by State Council of the People’s Republic of China in 2007. He has been an independent non-executive director of Alphamab Oncology, a company listed on the Stock Exchange (stock code: 9966), since November 2019. 

 

Dr. Jiang received his bachelor’s degree in chemistry from Nanjing University (南京大学) in July 1987, his master’s degree in physical chemistry from East China Normal University (华东师范大学) in July 1997 and his doctoral degree in medicinal chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences (中国科学院上海药物研究所) in July 1995.